EUVIMEDEUVIMED entdecken
Open Access

Prevalence and determinants of hepatitis delta virus infection among HIV /hepatitis B‐coinfected adults in care in the United States

Nicole D Ferrante, Michael J Kallan, Sophia Sukkestad, Maja Kodani, Mari M Kitahata, Edward R Cachay, Debika Bhattacharya, Sonya Heath, Sonia Napravnik, Richard D Moore, George Yendewa iD, Kenneth H Mayer und 6 weitere

Journal of Viral Hepatitis · 2023

DOI: 10.1111/jvh.13874 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Viral Hepatitis, 2023. Verfasst von Nicole D Ferrante und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Gastroenterology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Coinfection, HIV Infections, Hepatitis B. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIDA NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis delta virus (HDV) infection increases the risk of liver complications compared to hepatitis B virus (HBV) alone, particularly among persons with human immunodeficiency virus (HIV). However, no studies have evaluated the prevalence or determinants of HDV infection among people with HIV/HBV in the US. We performed a cross‐sectional study among adults with HIV/HBV coinfection receiving care at eight sites within the Center for AIDS Research Network of Integrated Clinical Systems (CNICS) between 1996 and 2019. Among patients with available serum/plasma specimens, we selected the first specimen on or after their initial HBV qualifying test. All samples were tested for HDV IgG antibody and HDV RNA. Multivariable log‐binomial generalized linear models were used to estimate prevalence ratios (PRs) with 95% CIs of HDV IgG antibody‐positivity associated with determinants of interest (age, injection drug use [IDU], high‐risk sexual behaviour). Among 597 adults with HIV/HBV coinfection in CNICS and available serum/plasma samples (median age, 43 years; 89.9% male; 52.8% Black; 42.4% White), 24/597 (4.0%; 95% CI, 2.4%–5.6%) were HDV IgG antibody‐positive, and 10/596 (1.7%; 95% CI, 0.6%–2.7%) had detectable HDV RNA. In multivariable analysis, IDU was associated with exposure to HDV infection (adjusted PR = 2.50; 95% CI, 1.09–5.74). In conclusion, among a sample of adults with HIV/HBV coinfection in care in the US, 4.0% were HDV IgG antibody‐positive, among whom 41.7% had detectable HDV RNA. History of IDU was associated with exposure to HDV infection. These findings emphasize the importance of HDV testing among persons with HIV/HBV coinfection, especially those with a history of IDU.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CoinfectionHIV InfectionsHepatitis BHumansAdultMaleUnited StatesFemaleHepatitis Delta VirusHIVPrevalenceCross-Sectional StudiesHepatitis B virusRNAHepatitis AntibodiesImmunoglobulin G

Stichwörter der Autor:innen

HIV HBV and HDV coinfectionepidemiologyhepatitis B virushepatitis delta virusprevalence

Substanzen

RNAHepatitis AntibodiesImmunoglobulin G

Autor:innen und Institutionen

  • Department of Medicine, Division of Gastroenterology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Biostatistics, Epidemiology, and Informatics, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Department of Medicine, Division of Allergy and Infectious Disease, University of Washington School of Medicine, Seattle, Washington, USA.
  • Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, California, USA.

ORCID-Profile: George Yendewa, H Nina Kim, Vincent Lo Re

Förderung

  • NIAID NIH HHS
  • NIDA NIH HHS
  • NIDDK NIH HHS
  • CDC HHS
  • Center for AIDS Research, University of Washington
  • Center for AIDS Research, University of North Carolina at Chapel Hill
  • Centers for Disease Control and Prevention
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Ferrante, N. D., Kallan, M. J., Sukkestad, S., Kodani, M., Kitahata, M. M., Cachay, E. R., Bhattacharya, D., Heath, S., Napravnik, S., Moore, R. D., Yendewa, G., Mayer, K. H., Reddy, K. R., Hayden, T., Kamili, S., Martin, J. N., Kim, H. N., & Lo Re, V. (2023). Prevalence and determinants of hepatitis delta virus infection among HIV /hepatitis B‐coinfected adults in care in the United States. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.13874

Vancouver

Ferrante ND, Kallan MJ, Sukkestad S, Kodani M, Kitahata MM, Cachay ER, et al. Prevalence and determinants of hepatitis delta virus infection among HIV /hepatitis B‐coinfected adults in care in the United States. Journal of Viral Hepatitis. 2023. doi:10.1111/jvh.13874

BibTeX
@article{Ferrante2023,
  author = {Ferrante, Nicole D and Kallan, Michael J and Sukkestad, Sophia and Kodani, Maja and Kitahata, Mari M and Cachay, Edward R and Bhattacharya, Debika and Heath, Sonya and Napravnik, Sonia and Moore, Richard D and Yendewa, George and Mayer, Kenneth H and Reddy, K Rajender and Hayden, Tonya and Kamili, Saleem and Martin, Jeffrey N and Kim, H Nina and Lo Re, Vincent},
  title = {Prevalence and determinants of hepatitis delta virus infection among HIV /hepatitis B‐coinfected adults in care in the United States},
  journal = {Journal of Viral Hepatitis},
  year = {2023},
  doi = {10.1111/jvh.13874}
}
Kostenlos starten →